Adverse drug events account for many preventable ED visits and hospital admissions. Canadian researchers have recently published a descriptive study that examined repeat adverse drug events associated with outpatient medications. Clinical pharmacists and physicians...
Tardive dyskinesia (TD) is a disabling and disfiguring movement disorder seen amongst people who have received long-term treatment with antipsychotic drugs.Treatment options are limited, but a recently published open-label long-term study has assessed the effects of...
The World Health Organization (WHO) have launched Medication Without Harm, as a part of their Global Patient Safety Challenge. One excellent resource that can be accessed (HERE) is a Powerpoint presentation that addresses Medication Safety – this identifies high...
The Australian Commission for Safety and Quality in Healthcare has released it’s report: THE STATE OF PATIENT SAFETY AND QUALITY IN AUSTRALIAN HOSPITALS 2019. The detailed report addresses a range of important issues, including some specific to medication...
A retrospective study of 11,557 people treated in ED for a non-fatal overdose in the USA has examined the ultimate outcome of death from any cause within 1 year of overdose treatment. Of these 635 (5.5%) died within 1 year, 130 (1.1%) died within 1 month, and 29...
